Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma

Young Seok Seo, Hyung Jun Yoo, Sung Yul Yoo, Chul Koo Cho, Kwang Mo Yang, Mi Sook Kim, Chul Won Choi, Young Ju Shin, Dong Han Lee, Guk Hang Lee

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Purpose: We reviewed survival, local control, and toxicity in patients with locally recurrent nasopharyngeal carcinoma (NPC) who had been treated with fractionated stereotactic radiotherapy (FSRT). Materials and methods: Between June 2002 and March 2008, we retrospectively reviewed 35 patients with locally recurrent NPC treated using FSRT with CyberKnife. Gross tumor volumes ranged from 2.6 to 64.0 ml (median, 7.9 ml). Radiation doses were prescribed at the isodose line (75-84% of the maximum dose; median, 80%). The prescribed dose of FSRT ranged from 24 to 45 Gy (median, 33 Gy) in three or five fractions. Results: The overall survival (OS) rate, local failure-free survival (LFFS) rate, and disease progression-free survival (DPFS) rate at 5 years were 60%, 79%, and 74%, respectively. Twenty-three patients achieved complete response after FSRT. Only T stage at recurrence was an independent prognostic factor for OS and DPFS. Five patients exhibited severe late toxicity (Grade 4 or 5). Conclusions: With regard to OS and LFFS, our study provided favorable outcomes. The incidence of severe late toxicities was acceptable in our study. FSRT would be considered as the alternative treatment of choice in re-irradiation for locally recurrent NPC.

Original languageEnglish
Pages (from-to)570-574
Number of pages5
JournalRadiotherapy and Oncology
Volume93
Issue number3
DOIs
Publication statusPublished - 2009 Dec 1
Externally publishedYes

Fingerprint

Robotics
Radiotherapy
Disease-Free Survival
Survival
Survival Rate
Disease Progression
Tumor Burden
Nasopharyngeal carcinoma
Radiation
Recurrence
Incidence

Keywords

  • CyberKnife
  • Fractionation
  • Recurrent nasopharyngeal carcinoma
  • Stereotactic

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Seo, Y. S., Yoo, H. J., Yoo, S. Y., Cho, C. K., Yang, K. M., Kim, M. S., ... Lee, G. H. (2009). Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma. Radiotherapy and Oncology, 93(3), 570-574. https://doi.org/10.1016/j.radonc.2009.10.018

Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma. / Seo, Young Seok; Yoo, Hyung Jun; Yoo, Sung Yul; Cho, Chul Koo; Yang, Kwang Mo; Kim, Mi Sook; Choi, Chul Won; Shin, Young Ju; Lee, Dong Han; Lee, Guk Hang.

In: Radiotherapy and Oncology, Vol. 93, No. 3, 01.12.2009, p. 570-574.

Research output: Contribution to journalArticle

Seo, YS, Yoo, HJ, Yoo, SY, Cho, CK, Yang, KM, Kim, MS, Choi, CW, Shin, YJ, Lee, DH & Lee, GH 2009, 'Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma', Radiotherapy and Oncology, vol. 93, no. 3, pp. 570-574. https://doi.org/10.1016/j.radonc.2009.10.018
Seo, Young Seok ; Yoo, Hyung Jun ; Yoo, Sung Yul ; Cho, Chul Koo ; Yang, Kwang Mo ; Kim, Mi Sook ; Choi, Chul Won ; Shin, Young Ju ; Lee, Dong Han ; Lee, Guk Hang. / Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma. In: Radiotherapy and Oncology. 2009 ; Vol. 93, No. 3. pp. 570-574.
@article{2986845477c54b109e55fada15d2b5f0,
title = "Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma",
abstract = "Purpose: We reviewed survival, local control, and toxicity in patients with locally recurrent nasopharyngeal carcinoma (NPC) who had been treated with fractionated stereotactic radiotherapy (FSRT). Materials and methods: Between June 2002 and March 2008, we retrospectively reviewed 35 patients with locally recurrent NPC treated using FSRT with CyberKnife. Gross tumor volumes ranged from 2.6 to 64.0 ml (median, 7.9 ml). Radiation doses were prescribed at the isodose line (75-84{\%} of the maximum dose; median, 80{\%}). The prescribed dose of FSRT ranged from 24 to 45 Gy (median, 33 Gy) in three or five fractions. Results: The overall survival (OS) rate, local failure-free survival (LFFS) rate, and disease progression-free survival (DPFS) rate at 5 years were 60{\%}, 79{\%}, and 74{\%}, respectively. Twenty-three patients achieved complete response after FSRT. Only T stage at recurrence was an independent prognostic factor for OS and DPFS. Five patients exhibited severe late toxicity (Grade 4 or 5). Conclusions: With regard to OS and LFFS, our study provided favorable outcomes. The incidence of severe late toxicities was acceptable in our study. FSRT would be considered as the alternative treatment of choice in re-irradiation for locally recurrent NPC.",
keywords = "CyberKnife, Fractionation, Recurrent nasopharyngeal carcinoma, Stereotactic",
author = "Seo, {Young Seok} and Yoo, {Hyung Jun} and Yoo, {Sung Yul} and Cho, {Chul Koo} and Yang, {Kwang Mo} and Kim, {Mi Sook} and Choi, {Chul Won} and Shin, {Young Ju} and Lee, {Dong Han} and Lee, {Guk Hang}",
year = "2009",
month = "12",
day = "1",
doi = "10.1016/j.radonc.2009.10.018",
language = "English",
volume = "93",
pages = "570--574",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma

AU - Seo, Young Seok

AU - Yoo, Hyung Jun

AU - Yoo, Sung Yul

AU - Cho, Chul Koo

AU - Yang, Kwang Mo

AU - Kim, Mi Sook

AU - Choi, Chul Won

AU - Shin, Young Ju

AU - Lee, Dong Han

AU - Lee, Guk Hang

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Purpose: We reviewed survival, local control, and toxicity in patients with locally recurrent nasopharyngeal carcinoma (NPC) who had been treated with fractionated stereotactic radiotherapy (FSRT). Materials and methods: Between June 2002 and March 2008, we retrospectively reviewed 35 patients with locally recurrent NPC treated using FSRT with CyberKnife. Gross tumor volumes ranged from 2.6 to 64.0 ml (median, 7.9 ml). Radiation doses were prescribed at the isodose line (75-84% of the maximum dose; median, 80%). The prescribed dose of FSRT ranged from 24 to 45 Gy (median, 33 Gy) in three or five fractions. Results: The overall survival (OS) rate, local failure-free survival (LFFS) rate, and disease progression-free survival (DPFS) rate at 5 years were 60%, 79%, and 74%, respectively. Twenty-three patients achieved complete response after FSRT. Only T stage at recurrence was an independent prognostic factor for OS and DPFS. Five patients exhibited severe late toxicity (Grade 4 or 5). Conclusions: With regard to OS and LFFS, our study provided favorable outcomes. The incidence of severe late toxicities was acceptable in our study. FSRT would be considered as the alternative treatment of choice in re-irradiation for locally recurrent NPC.

AB - Purpose: We reviewed survival, local control, and toxicity in patients with locally recurrent nasopharyngeal carcinoma (NPC) who had been treated with fractionated stereotactic radiotherapy (FSRT). Materials and methods: Between June 2002 and March 2008, we retrospectively reviewed 35 patients with locally recurrent NPC treated using FSRT with CyberKnife. Gross tumor volumes ranged from 2.6 to 64.0 ml (median, 7.9 ml). Radiation doses were prescribed at the isodose line (75-84% of the maximum dose; median, 80%). The prescribed dose of FSRT ranged from 24 to 45 Gy (median, 33 Gy) in three or five fractions. Results: The overall survival (OS) rate, local failure-free survival (LFFS) rate, and disease progression-free survival (DPFS) rate at 5 years were 60%, 79%, and 74%, respectively. Twenty-three patients achieved complete response after FSRT. Only T stage at recurrence was an independent prognostic factor for OS and DPFS. Five patients exhibited severe late toxicity (Grade 4 or 5). Conclusions: With regard to OS and LFFS, our study provided favorable outcomes. The incidence of severe late toxicities was acceptable in our study. FSRT would be considered as the alternative treatment of choice in re-irradiation for locally recurrent NPC.

KW - CyberKnife

KW - Fractionation

KW - Recurrent nasopharyngeal carcinoma

KW - Stereotactic

UR - http://www.scopus.com/inward/record.url?scp=70449657750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449657750&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2009.10.018

DO - 10.1016/j.radonc.2009.10.018

M3 - Article

C2 - 19919887

AN - SCOPUS:70449657750

VL - 93

SP - 570

EP - 574

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 3

ER -